Statistical methods in medical research, Blackwell Scientific Publications, pp.279-301, 1980. ,
Structural bases of vasopressin/oxytocin receptor function, Journal of Endocrinology, vol.156, issue.2, pp.223-229, 1998. ,
DOI : 10.1677/joe.0.1560223
Vasopressin Receptors, Trends in Endocrinology & Metabolism, vol.11, issue.10, pp.406-410, 2000. ,
DOI : 10.1016/S1043-2760(00)00304-0
Isolation and characterization of a cDNA clone encoding for rat CSF-1 gene. Post-transcriptional repression occurs in myogenic differentiation, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1174, issue.2, pp.143-152, 1993. ,
DOI : 10.1016/0167-4781(93)90108-P
Molecular Cloning of CSF-1 Receptor from Rat Myoblasts. Sequence Analysis and Regulation During Myogenesis, Growth Factors, vol.56, issue.4, pp.209-218, 1992. ,
DOI : 10.3109/08977199209021534
Colony-Stimulating Factor 1 (CSF-1)Is Involved in an Autocrine Growth Control of Rat Myogenic Cells, Experimental Cell Research, vol.218, issue.1, pp.213-222, 1995. ,
DOI : 10.1006/excr.1995.1149
Muscle disorders associated with cyclosporine treatment, Muscle & Nerve, vol.1241, issue.12, pp.1631-1636, 1999. ,
DOI : 10.1002/(SICI)1097-4598(199912)22:12<1631::AID-MUS3>3.0.CO;2-V
Presence of Functional Oxytocin Receptors in Cultured Human Myoblasts, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.3, pp.1415-1418, 2002. ,
DOI : 10.1210/jcem.87.3.8537
Stability Regulation of mRNA and the Control of Gene Expression, Annals of the New York Academy of Sciences, vol.1058, issue.1, pp.196-204, 2005. ,
DOI : 10.1196/annals.1359.026
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction, Biochem Pharmacol, vol.22, pp.3099-3108, 1973. ,
receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment, British Journal of Pharmacology, vol.117, issue.Suppl 11, pp.909-917, 2001. ,
DOI : 10.1038/sj.bjp.0703878
The RNA-binding Protein HuR Binds to Acetylcholinesterase Transcripts and Regulates Their Expression in Differentiating Skeletal Muscle Cells, Journal of Biological Chemistry, vol.280, issue.27, pp.25361-25368, 2005. ,
DOI : 10.1074/jbc.M410929200
Role of HuR in Skeletal Myogenesis through Coordinate Regulation of Muscle Differentiation Genes, Molecular and Cellular Biology, vol.23, issue.14, pp.4991-5004, 2003. ,
DOI : 10.1128/MCB.23.14.4991-5004.2003
Intermediate-conductance Ca2+-activated K+ channel is expressed in C2C12 myoblasts and is downregulated during myogenesis, AJP: Cell Physiology, vol.289, issue.1, pp.89-96, 2005. ,
DOI : 10.1152/ajpcell.00369.2004
Down-regulation of an ankyrin repeat-containing protein, V-1, during skeletal muscle differentiation and its re-expression in the regenerative process of muscular dystrophy, Neuromuscular Disorders, vol.13, issue.1, pp.32-41, 2003. ,
DOI : 10.1016/S0960-8966(02)00185-2
Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor, European Journal of Biochemistry, vol.171, issue.2, pp.711-719, 1993. ,
DOI : 10.1016/0006-8993(88)91437-0
The molecular basis of skeletal muscle atrophy, AJP: Cell Physiology, vol.287, issue.4, pp.834-843, 2004. ,
DOI : 10.1152/ajpcell.00579.2003
Phospholipase D Is Involved in Myogenic Differentiation through Remodeling of Actin Cytoskeleton, Molecular Biology of the Cell, vol.16, issue.3, pp.1232-1244, 2005. ,
DOI : 10.1091/mbc.E04-06-0459
Vasopressin type 1A receptor upregulation by cyclosporin A in vascular smooth muscle cells is mediated by superoxide, J Biol Chem, vol.278, pp.1685-41690, 2003. ,
Involvement of histone H4 gene transcription factor 1 in downregulation of vimentin gene expression during skeletal muscle differentiation, FEBS Letters, vol.7, issue.1-2, pp.30-34, 2001. ,
DOI : 10.1016/S0014-5793(01)02142-1
DNA Methylation of the Human Oxytocin Receptor Gene Promoter Regulates Tissue-Specific Gene Suppression, Biochemical and Biophysical Research Communications, vol.289, issue.3, pp.681-686, 2001. ,
DOI : 10.1006/bbrc.2001.6024
Vasopressin and insulin-like growth factors synergistically induce myogenesis in serum-free medium, Cell Growth Diff, vol.9, pp.155-163, 1998. ,
Molecular cloning and expression of a rat Via arginine vasopressin receptor, Nature, vol.356, issue.6369, pp.523-526, 1992. ,
DOI : 10.1038/356523a0
Glucocorticoids Regulate V1a Vasopressin Receptor Expression by Increasing mRNA Stability in Vascular Smooth Muscle Cells, Hypertension, vol.26, issue.4, pp.665-669, 1995. ,
DOI : 10.1161/01.HYP.26.4.665
A Bimodal Modulation of the cAMP Pathway Is Involved in the Control of Myogenic Differentiation in L6 Cells, Journal of Biological Chemistry, vol.278, issue.49, pp.49308-49315, 2003. ,
DOI : 10.1074/jbc.M306941200
Role of phospholipase C and D signalling pathways in vasopressin-dependent myogenic differentiation, Journal of Cellular Physiology, vol.61, issue.1, pp.34-42, 1997. ,
DOI : 10.1002/(SICI)1097-4652(199704)171:1<34::AID-JCP5>3.0.CO;2-I
Phosphatidic acid-dependent activation of adenosine-3???,5???-cyclic-monophosphate-phosphodiesterase is necessary for arg-vasopressin induction of myogenesis, Lipids, vol.51, issue.S1, pp.81-82, 1999. ,
DOI : 10.1007/BF02562238
Arginine-vasopressin induces differentiation of skeletal myogenic cells and upregulation of myogenin and myf-5, Cell Growth Diff, vol.6, pp.81-89, 1995. ,
Distribution of V1a and V2 vasopressin receptor mRNA in rat liver, kidney, pituitary and brain, Endocrinology, vol.131, pp.533-535, 1992. ,
Molecular mechanisms regulating myogenic determination and differentiation, Frontiers in Bioscience, vol.5, issue.3, pp.750-767, 2000. ,
DOI : 10.2741/A548
Central effects of oxytocin, Physiol Rev, vol.71, pp.331-370, 1991. ,
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development, Current Pharmaceutical Design, vol.11, issue.2, pp.205-225, 2005. ,
DOI : 10.2174/1381612053382241
Putative Physiological Significance of Vasopressin V1a Receptor Activation in Rat Pituicytes, Journal of Neuroendocrinology, vol.16, issue.4, pp.313-318, 2004. ,
DOI : 10.1111/j.0953-8194.2004.01160.x
Molecular cloning: a laboratory manual, 1989. ,
Immunoreactive arginine vasopressin in human fetal and neonatal skeletal muscle, Early Human Development, vol.28, issue.3, pp.215-222, 1992. ,
DOI : 10.1016/0378-3782(92)90168-G
Transduction of the arginine-vasopressin signal in skeletal myogenic cells, Am J Physiol, vol.265, issue.C34, pp.113-121, 1993. ,
Stimulation of protein synthesis and phospholipase D activity by vasopressin and phorbol ester in L6 myoblasts, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1224, issue.2, pp.198-204, 1994. ,
DOI : 10.1016/0167-4889(94)90191-0
Regulation of Cyclins and P34CDC2 Expression during Terminal Differentiation of C2C12 Myocytes, Biochemical and Biophysical Research Communications, vol.206, issue.1, pp.82-88, 1995. ,
DOI : 10.1006/bbrc.1995.1012
Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene, Peptides, vol.17, issue.1, pp.67-73, 1996. ,
DOI : 10.1016/0196-9781(95)02085-3
Glucocorticoid regulation of vasopressin V1a receptors in rat forebrain, Molecular Brain Research, vol.38, issue.2, pp.276-284, 1996. ,
DOI : 10.1016/0169-328X(95)00345-S